BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32233763)

  • 41. Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland.
    Paltta J; Suuronen S; Pirilä L; Palomäki A
    Scand J Rheumatol; 2023 Nov; 52(6):689-695. PubMed ID: 37335188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of patients with polymyalgia rheumatica: limitations to get it right.
    Manzo C; Natale M; Nune A; Castagna A
    Clin Exp Rheumatol; 2023 Sep; 41 Suppl 135(9):22. PubMed ID: 36719744
    [No Abstract]   [Full Text] [Related]  

  • 43. Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?
    Cowley S; Harkins P; Kirby C; Conway R; Kane DJ
    Ann Rheum Dis; 2024 Mar; ():. PubMed ID: 38553044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review.
    Coskun Benlidayi I
    Clin Rheumatol; 2024 Mar; 43(3):851-861. PubMed ID: 37470883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline Characteristics and Clinical Presentation of Biopsy-Proven Giant Cell Arteritis in White Compared with Black Patients.
    Sun E; Li X; Gruener AM; Chang JR; Henderson AD; Carey AR
    J Neuroophthalmol; 2023 Dec; 43(4):504-508. PubMed ID: 36862509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the American College of Rheumatology RISE Registry.
    Sattui SE; Xie F; Wan Z; Clinton C; Domsic RT; Curtis JR
    Arthritis Care Res (Hoboken); 2024 Feb; 76(2):259-264. PubMed ID: 37563714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.
    Chatzigeorgiou C; Taylor JC; Elliott F; O'Sullivan EP; Morgan AW; Barrett JH; Mackie SL
    Rheumatol Adv Pract; 2023; 7(3):rkad095. PubMed ID: 38033363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically determined iron status was associated with polymyalgia rheumatica but not with giant cell arteritis: A Mendelian randomization analysis.
    Xiao X; Li S
    Int J Rheum Dis; 2024 Jan; 27(1):e14841. PubMed ID: 37477187
    [No Abstract]   [Full Text] [Related]  

  • 49. Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group.
    Keller KK; Mukhtyar CB; Nielsen AW; Hemmig AK; Mackie SL; Sattui SE; Hauge EM; Dua A; Helliwell T; Neill L; Blockmans D; Devauchelle-Pensec V; Hayes E; Venneboer AJ; Monti S; Ponte C; De Miguel E; Matza M; Warrington KJ; Byram K; Yaseen K; Peoples C; Putman M; Lally L; Finikiotis M; Appenzeller S; Caramori U; Toro-Gutiérrez CE; Backhouse E; Oviedo MCG; Pimentel-Quiroz VR; Keen HI; Owen CE; Daikeler T; de Thurah A; Schmidt WA; Brouwer E; Dejaco C
    Ann Rheum Dis; 2023 Dec; ():. PubMed ID: 38050004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sarilumab for polymyalgia rheumatica].
    Schmidt WA
    Z Rheumatol; 2024 Mar; 83(2):151-152. PubMed ID: 38240818
    [No Abstract]   [Full Text] [Related]  

  • 51. Getting it right for polymyalgia rheumatica.
    Mukhtyar CB; Twohig H; Hodgson H
    Rheumatology (Oxford); 2022 Nov; 61(11):4221-4222. PubMed ID: 35311988
    [No Abstract]   [Full Text] [Related]  

  • 52. Imaging findings in Giant Cell Arteritis: Don't Turn A Blind Eye To The Obvious!
    Bathla G; Agarwal AK; Messina SA; Black DF; Soni N; Diehn FE; Campeau NG; Lehman VT; Warrington KJ; Rhee RL; Bley TA
    AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38906672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    Aletaha D
    N Engl J Med; 2023 Oct; 389(14):1328-1329. PubMed ID: 37792617
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.
    Ghosh N; Couette N; van Binsbergen WH; Weinmann SC; Jivanelli B; Shea B; Bass AR; Benesova K; Bingham CO; Calabrese C; Cappelli LC; Chan KK; Choy E; Daoussis D; Goodman S; Hudson M; Jamal S; Leipe J; Lopez-Olivo MA; Suarez-Almazor M; van der Laken CJ; Meara AS; Liew D; Kostine M
    Semin Arthritis Rheum; 2023 Feb; 58():152110. PubMed ID: 36372016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, Serological, and Immunological Characteristics of Greek Patients with Polymyalgia Rheumatica and/or Giant Cell Arteritis: A Research Protocol.
    Memi T; Koletsos N; Gerolymatou N; Karakosta M; Georgiadis AN; Drosos AA; Voulgari PV
    Mediterr J Rheumatol; 2023 Dec; 34(4):577-580. PubMed ID: 38282939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis.
    Sugihara T; Uchida HA; Yoshifuji H; Maejima Y; Naniwa T; Katsumata Y; Okazaki T; Ishizaki J; Murakawa Y; Ogawa N; Dobashi H; Horita T; Tanaka Y; Furuta S; Takeuchi T; Komagata Y; Nakaoka Y; Harigai M
    Mod Rheumatol; 2023 Nov; 33(6):1145-1153. PubMed ID: 36218378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed.
    Manzo C
    Semin Arthritis Rheum; 2023 Dec; 63():152309. PubMed ID: 37951127
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnostics and treatment of large vessel vasculitis].
    Bauer CJ; Schäfer VS
    Inn Med (Heidelb); 2024 Feb; 65(2):107-113. PubMed ID: 38240814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
    Seitz P; Cullmann J; Bucher S; Bütikofer L; Reichenbach S; Lötscher F; Amsler J; Christ L; Bonel HM; Villiger PM; Seitz L
    Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38265241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarkers as predicting factors for relapse in polymyalgia rheumatica: the importance of alkaline phosphatase.
    Ishiguro K; Yamashita H; Shimizu Y; Kaneko H
    Rheumatology (Oxford); 2023 Oct; 62(10):e288-e290. PubMed ID: 37014366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.